What is World Precision Instruments?
With a legacy spanning over 55 years, World Precision Instruments has established itself as a cornerstone provider of specialized laboratory instrumentation. The company serves a diverse clientele across the pharmaceutical, healthcare, and industrial sectors, offering a sophisticated portfolio that includes TEER measurement systems, microinjection technology, and advanced electrophysiology tools. By prioritizing research innovation, the firm enables scientists to conduct rigorous drug validation and testing, ensuring that experimental integrity remains at the forefront of modern scientific discovery. Their commitment to precision engineering has made them an essential partner for laboratories seeking to optimize complex workflows and enhance the reliability of their data outputs.
How much funding has World Precision Instruments raised?
World Precision Instruments has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in World Precision Instruments
PPP
Public-Private Partnership
What's next for World Precision Instruments?
Looking ahead, the recent capital allocation is expected to catalyze the next phase of the company's growth trajectory. As the firm transitions through this late-stage funding cycle, strategic priorities will likely shift toward scaling production capabilities and accelerating the development of next-generation diagnostic tools. By integrating this financing into their long-term operational strategy, World Precision Instruments is well-equipped to navigate the evolving demands of the global life sciences market, ensuring that their suite of laboratory solutions continues to meet the stringent requirements of modern pharmaceutical research and industrial testing environments.
See full World Precision Instruments company page
